OTICAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oticair, and what generic alternatives are available?
Oticair is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs.
The generic ingredient in OTICAIR is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OTICAIR?
- What are the global sales for OTICAIR?
- What is Average Wholesale Price for OTICAIR?
Summary for OTICAIR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 8 |
| DailyMed Link: | OTICAIR at DailyMed |
Pharmacology for OTICAIR
| Drug Class | Aminoglycoside Antibacterial Corticosteroid Polymyxin-class Antibacterial |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for OTICAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | OTICAIR | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 064065-001 | Aug 28, 1996 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pharmafair | OTICAIR | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OTIC | 062399-001 | Nov 18, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
